NP213 (Novexatin(®)): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile

NP213 (Novexatin(®)) is a novel antifungal peptide specifically designed for the topical treatment of onychomycosis. NP213 was designed using host defense peptides (HDP), essential components of the innate immune response to infection, as a template. NP213 is a water-soluble cyclic fungicidal peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercer, Derry K, Robertson, Jennifer C, Miller, Lorna, Stewart, Colin S, O'Neil, Deborah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657096/
https://www.ncbi.nlm.nih.gov/pubmed/32232410
http://dx.doi.org/10.1093/mmy/myaa015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657096/
https://www.ncbi.nlm.nih.gov/pubmed/32232410
http://dx.doi.org/10.1093/mmy/myaa015

Ejemplares similares